profit from every $100 of sales.
$0$100
Edgewell Personal Care
$29.15-1.55% today
+57.0% in 1 year
1-year low $15.911-year high $29.66
Trading close to its highest price of the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay $52.89 for every $1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Edgewell Personal Care sold, what it kept, and what it did with the cash.
Sales went from $2.17 billion in 2022 to $2.22 billion in 2025, with $25.4 million of profit last year.
SalesProfit
Edgewell Personal Care handed back more cash to shareholders than it generated last year.
Buybacks $90M$29M
Free cash flow 2025$41M
Bought back its own shares$90M
Paid as dividends$29M
Cash vs. debt$226M vs. $1.4B
Edgewell Personal Care vs. similar companies
Edgewell Personal Care grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Edgewell Personal Care | 52.9× · Expensive | ||
 Procter & Gamble | 24.2× · Fair price | ||
 L'Oréal | 38.9× · Expensive | ||
 Unilever | 13.5× · Cheap | ||
 Colgate-Palmolive | 36.5× · Expensive |
AI analysis
An AI analyst reads Edgewell Personal Care's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 2,172 | 2,252 | 2,254 | 2,224 | |
| 881 | 941 | 956 | 925 | |
| 198 | 244 | 235 | 196 | |
| 285 | 318 | 285 | 186 | |
| 100 | 115 | 99 | 25 | |
| 1.84 | 2.18 | 1.97 | 0.53 | |
| 40.5% | 41.8% | 42.4% | 41.6% | |
| 9.1% | 10.8% | 10.4% | 8.8% | |
| 4.6% | 5.1% | 4.4% | 1.1% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 3,713 | 3,741 | 3,731 | 3,756 |
| Cash | 189 | 216 | 209 | 226 |
| Total debt | 1,410 | 1,380 | 1,300 | 1,413 |
| Total liabilities | 2,246 | 2,200 | 2,147 | 2,203 |
| 1,467 | 1,541 | 1,584 | 1,553 | |
| 54 | 52 | 50 | 48 | |
| 5.4% | 6.1% | 5.4% | 2.6% | |
| 6.8% | 7.4% | 6.2% | 1.6% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 102 | 216 | 231 | 118 | |
| 56 | 50 | 57 | 77 | |
| 46 | 167 | 175 | 41 | |
| Dividends paid | 33 | 32 | 31 | 29 |
| 125 | 75 | 59 | 90 | |
| 24 | 28 | 27 | 25 |
Valuation
- 52.9×
- 15.4×
- –
- 0.5×
- 0.6×
- 32.5×
- 13.6×
- 3.1%
- 1.9%
- 3.8%
Profitability
- 41.6%
- 8.8%
- 1.1%
- 6.3%
- 1.3%
- 3.1%
- -5.1%
- -2.2%
- 2.1%
- 2.8%
Growth
- +0.8%
- −34.0%
- −76.3%
- +32.0%
- −3.3%
Financial health
- 7.4×
- 0.88
- 36.2%
- 0.9×
- 1.81
- 1.07
- 0.60
How it ranks in Consumer Staples
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 6%of 670
Bottom 44%of 674
Bottom 8%of 624
Bottom 22%of 673
Bottom 32%of 668
What analysts expect
- Average price target
- $23.67
- Range
- $21.00 – $26.00
- 4 analysts
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 6, 2026 | 0.60 | 0.43 | +39.5% |
| Feb 9, 2026 | -0.16 | -0.18 | +11.1% |
| Nov 13, 2025 | 0.68 | 0.82 | −17.1% |
| Aug 5, 2025 | 0.92 | 1.01 | −8.9% |
| May 7, 2025 | 0.87 | 0.90 | −3.3% |
| Feb 10, 2025 | 0.07 | 0.13 | −46.2% |
| Nov 7, 2024 | 0.72 | 0.67 | +7.5% |
| Aug 6, 2024 | 1.22 | 1.01 | +20.8% |
3.8%of the share price, paid each year
On $1,000 invested$38a year at today's yield, before tax
+32.0%2020 to 2025
Raised–not every year
Paid per share, each year
$0.99 in 2015 → $0.60 in 2025
How safe it looks
115.4% of its profit
Room to growStretchedMore than it earns: 70.8%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
29No pass
Benjamin Graham
59No pass
Philip Fisher
23No pass
Peter Lynch
15No pass
Joel Greenblatt
9No pass
Charlie Munger
25No pass
Terry Smith
28No pass
Questions about Edgewell Personal Care
Is Edgewell Personal Care a good stock to buy?
A business with weak numbers, but the price is high. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Edgewell Personal Care AI analysis
What does Edgewell Personal Care do?
Edgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet shave, Sun and Skin care, and Feminine care. It is in Household & Personal Products.
Does Edgewell Personal Care pay a dividend?
Yes. At today's price the dividend is 3.8% a year, about 115% of its yearly profit. In 2025 it paid out $29.3 million in dividends.
Is Edgewell Personal Care stock halal?
No. Edgewell Personal Care does not pass our halal screen: its debt is 105% of its market value, at or above the 33% limit. How we check
How has Edgewell Personal Care stock done over the past year?
Up 57.0% over the past twelve months, to $29.15. It traded between $15.91 and $29.66, close to its high.
Who are Edgewell Personal Care's competitors?
The largest listed companies in the same industry are Procter & Gamble, L'Oréal, Unilever and Colgate-Palmolive. The peers table on this page compares their profit, growth and price with Edgewell Personal Care's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.